# Journal of Cachexia Sarcopenia and Muscle

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/journal-of-cachexia-sarcopenia-and-muscle/

## Facts

| Field | Value |
| --- | --- |
| Open Access | true |
| ISSN-L | 2190-5991 |
| ISSNs | 2190-5991,2190-6009 |
| OpenAlex ID | https://openalex.org/S173726759 |
| Publisher | Springer Science+Business Media |

## Journal papers

Showing 12 of 29.

- [GLIM criteria for the diagnosis of malnutrition – A consensus report from the global clinical nutrition community](https://scholariq.org/papers/glim-criteria-for-the-diagnosis-of-malnutrition-a-consensus-report-from-the-2/)
- [Welcome to the ICD‐10 code for sarcopenia](https://scholariq.org/papers/welcome-to-the-icd-10-code-for-sarcopenia/)
- [An overview of sarcopenia: facts and numbers on prevalence and clinical impact](https://scholariq.org/papers/an-overview-of-sarcopenia-facts-and-numbers-on-prevalence-and-clinical-impact/)
- [Pitfalls in the measurement of muscle mass: a need for a reference standard](https://scholariq.org/papers/pitfalls-in-the-measurement-of-muscle-mass-a-need-for-a-reference-standard/)
- [Sarcopenia: A Time for Action. An SCWD Position Paper](https://scholariq.org/papers/sarcopenia-a-time-for-action-an-scwd-position-paper/)
- [Rehabilitation nutrition for sarcopenia with disability: a combination of both rehabilitation and nutrition care management](https://scholariq.org/papers/rehabilitation-nutrition-for-sarcopenia-with-disability-a-combination-of-both/)
- [The Copenhagen Sarcopenia Study: lean mass, strength, power, and physical function in a Danish cohort aged 20–93 years](https://scholariq.org/papers/the-copenhagen-sarcopenia-study-lean-mass-strength-power-and-physical-function/)
- [Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis](https://scholariq.org/papers/elevated-serum-myostatin-level-is-associated-with-worse-survival-in-patients/)
- [The incidence of sarcopenia among hospitalized older patients: results from the Glisten study](https://scholariq.org/papers/the-incidence-of-sarcopenia-among-hospitalized-older-patients-results-from-the/)
- [Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non‐small cell lung cancer or colorectal cancer: a randomized, double‐blind, placebo‐controlled, international multicentre phase II study (the ACT‐ONE trial)](https://scholariq.org/papers/espindolol-for-the-treatment-and-prevention-of-cachexia-in-patients-with-stage/)
- [The regulatory approval of anamorelin for treatment of cachexia in patients with non‐small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.](https://scholariq.org/papers/the-regulatory-approval-of-anamorelin-for-treatment-of-cachexia-in-patients-with/)
- [Associations of metabolic heterogeneity of obesity with frailty progression: Results from two prospective cohorts](https://scholariq.org/papers/associations-of-metabolic-heterogeneity-of-obesity-with-frailty-progression/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.